Over the last decade, exciting changes have transformed the pharmaceutical industry. For example, scientific advancements, particularly those that have contributed to the rise in biologics, are increasing the complexity of patient treatments and pharmaceutical products. In addition, many manufacturers are expanding their global footprints to address unmet patient needs in smaller populations across the world.
As drug manufacturers continue to advance medicine with new discoveries in technology and science, the dominance of biologics is expected to continue, with experts predicting them to comprise more than a quarter of the pharmaceutical market by 2020.
In a critical care emergency, fast response and safe administration of blood can be the difference between life and death. Overcoming logistical issues such as how to control shelf life, how to maintain a suitable thermal environment for blood storage and transport, how to determine which patients need pre-hospital blood and what blood products to use in the pre-hospital environment are among the challenges.
It is the goal of this research to identify current packaging options that limit this environmental impact.
Payload Protection, Patient Safety
Cultivating a pharmaceutical manufacturing brand name synonymous with trust and delivery begins with the best product, diligence in implementing everything needed to ensure the product’s protection during transit, a “right the first time” delivery method and an expectation of safety for the patient.
The Great North Air Ambulance Service (GNAAS) operate three air ambulance helicopters, which fly across the Northeast, North Yorkshire and Cumbria regions in the UK. Relying on public donations to operate, the service provides pre-hospital care at the scene of accidents and incidents, rescuing hundreds of severely injured or ill patients every year...